Navigation Links
Cancer Experts Detail Treatments using TrueBeam System to Reduce Number of Treatment Sessions and Take Better Account of Motion

BARCELONA, Spain, May 11, 2012 /PRNewswire/ -- European cancer experts have reported their progress with promising new radiosurgical techniques for treating cancer and other conditions using new linear accelerator technology from Varian Medical Systems (NYSE: VAR). Speakers at Varian's Emerging Technologies Symposium at the annual ESTRO conference detailed their experiences with fast hypo-fractionated treatments for prostate patients and RapidArc® Radiosurgery for intracranial and central nervous system indications.

Dr. Filippo Alongi, radiation oncologist at Humanitas Cancer Center in Rozzano-Milan, reported that he has used hypo-fractionation to reduce the number of treatment sessions for prostate cancer from 30 to as few as five.  The center is equipped with Varian's versatile TrueBeam system for radiotherapy and radiosurgery. 

"Our work at Humanitas is demonstrating that hypo-fractionation with TrueBeam is a precise and fast option for prostate cancer patients," said Dr. Alongi. "Each treatment is delivered in under five minutes and this compares very favorably against dedicated radiosurgical tools which can take 45 minutes per treatment session. We are giving the same dose with the same quality in a fraction of that time, and enabling patients to spend much less time on the treatment table."

Dr. Ufuk Abacioglu of Neolife Medical Center in Istanbul presented on the use of frameless, singe-fraction RapidArc® Radiosurgery for intracranial and central nervous system treatments, including malignant and benign tumors, vascular abnormalities and functional disorders. 

"Frameless, non-invasive localization of the target with image-guidance has made it possible for us to treat larger disease sites in fewer sessions while avoiding the invasive procedure of attaching a frame to the patient's skull," said Dr. Abacioglu. "Using TrueBeam's ultra-fast high intensity mode, image-guided radiosurgery can be completed in a standard 15 minute treatment slot rather than in conventional radiosurgery sessions that are typically two to five times longer. We are pleased with the clinical experience and patient response."

Prof. Carlo Greco from the University of Pisa in Italy described his clinic's experience with real-time tracking of prostate cancer using the Varian Calypso® system, which involves the use of implantable beacons to monitor motion by tracking movement in real time with sub-millimeter precision.

"Calypso enabled us to detect and measure motion during treatments so that we could plan to deliver doses within tighter margins around the disease site in order to reduce toxicity and complications in surrounding healthy tissue," said Prof. Greco. "Prostate motion occurs even during very short RapidArc treatments and detecting and correcting for this is of paramount importance when adopting hypo-fractionated schedules that involve delivering higher doses within each treatment session."

The Varian's Emerging Technologies Symposium was chaired and moderated by Professor Ben Slotman, head of radiation oncology at VU Medical Center in Amsterdam, The Netherlands.

Also at ESTRO 2012, Varian hosted a lunch symposium assessing different ways of delivering post-lumpectomy partial breast irradiation, with the relative benefits of external beam radiotherapy, intra-operative irradiation and brachytherapy examined. This session was moderated by Prof. Dr. Peter Niehoff of Koln Merheim Hospital in Germany and the debaters were Douglas Arthur, M.D. of Virginia Commonwealth University School of Medicine in the USA and Frank Sullivan, M.D. of Galway University Hospital in Ireland.  

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. Varian Medical Systems employs approximately 6,000 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit or follow us on Twitter.

*Devices mentioned in this press release may not have obtained regulatory clearance yet or are currently not available in all markets.

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Guangzhous Sun Yat-sen University Cancer Center Debuts MOSAIQ in the Chinese Platform
3. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
4. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
5. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
6. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
7. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
8. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
9. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the Global Cell Surface Testing Market: ... report to their offering.  --> ... addition of the  "2016 Future Horizons ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... November 29, 2015 , ... Effective immediately, every single ... addition starting on Black Friday Target is offering a “Buy One Scrub Set, Get ... a rare opportunity to purchase IguanaMed at a discounted price. , IguanaMed’s ...
(Date:11/28/2015)... San Diego, California (PRWEB) , ... November 28, ... ... cloud-based medical image exchange technology and teleradiology services, has added Chris Hafey and ... prepares to exhibit at the Radiological Society of North America (RSNA) 2015 Annual ...
(Date:11/28/2015)... ... November 28, 2015 , ... Trying to relax on a couch can ... "I conceived of this design due to personal experience with a bad back," he ... relaxation and convenience, as well as increases support. It also makes it easier to ...
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published November ... meeting in Washington D.C. revolved around the fact that proper dental care, both at-home ... stressed the link between periodontal disease (more commonly referred to as gum disease) and ...
Breaking Medicine News(10 mins):